Home › Funds › ACUTA CAPITAL PARTNERS, LLC › AVLN

ACUTA CAPITAL PARTNERS, LLC position in AVLN

AVALYN PHARMACEUTICALS INC · Health Care

ACUTA CAPITAL PARTNERS, LLC reported holding 114,749 shares of AVLN (AVALYN PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.3M, representing 2.58% of its reported portfolio and ranking #12 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)114.75K sh
Reported value held$3.27M
Portfolio Weight2.58%
First reportedQ2 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ACUTA CAPITAL PARTNERS, LLC's AVLN position evolved

ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in AVLN in Q2 2026 at 115,000 shares (US$3.8M). Across 2 filings, ACUTA CAPITAL PARTNERS, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 114,749 shares valued at US$3.3M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 115.00K $3.79M New
Q3 2026 114.75K $3.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AVLN and 13F data

AVLN (AVALYN PHARMACEUTICALS INC) is a Health Care company. 118 other funds we track also report a position in AVLN — the largest reported positions include Novo Holdings A/S (US$127.8M), SR ONE CAPITAL MANAGEMENT, LP (US$108.9M), PERCEPTIVE ADVISORS LLC (US$88.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AVLN

All AVLN fund holders →

FAQ

How long has ACUTA CAPITAL PARTNERS, LLC held AVLN?

ACUTA CAPITAL PARTNERS, LLC has disclosed AVLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is ACUTA CAPITAL PARTNERS, LLC's current position in AVLN?

As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 114.75K shares of AVLN (AVALYN PHARMACEUTICALS INC), valued at $3.27M, representing 2.58% of its reported portfolio and ranking #12.

Has ACUTA CAPITAL PARTNERS, LLC been buying or selling AVLN?

In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC held unchanged its position in AVLN.

Which other funds hold AVLN?

Other major institutional holders of AVLN include Novo Holdings A/S, SR ONE CAPITAL MANAGEMENT, LP, PERCEPTIVE ADVISORS LLC, among 118 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.